Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

5.67
Delayed Data
As of May 27
 +0.08 / +1.43%
Today’s Change
3.55
Today|||52-Week Range
23.39
-45.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$195.3M

Company Description

Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, and tissue and bone repair. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Contact Information

Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia Maryland 21046-1707
P:(443) 545-1800
Investor Relations:
(443) 545-1834

Employees

Shareholders

Other institutional8.97%
Individual stakeholders44.79%
Mutual fund holders15.21%

Top Executives

Bobby Dwayne MontgomeryPresident, Chief Executive Officer & Director
Frank D. CzworkaChief Operating Officer
Gregory I. LawChief Financial Officer, Secretary & Treasurer
Alla DanilkovitchChief Scientific Officer
Therésa K. DixonGeneral Manager-Market Access & Reimbursement